title: [Delayed elimination of methotrexate after high-dose infusion].
authors.forename: S A
authors.initials: SA
authors.lastname: Kuleva
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D001932:Brain Neoplasms / Q000188:drug therapy*; D017809:Fatal Outcome; D006207:Half-Life; D006333:Heart Failure / Q000139:chemically induced* / Q000628:therapy; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D006940:Hyperemia / Q000139:chemically induced; D007223:Infant; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000737:chemistry / Q000493:pharmacokinetics*; D052016:Mucositis / Q000139:chemically induced; D018242:Neuroectodermal Tumors, Primitive / Q000188:drug therapy*; D010198:Pancytopenia / Q000139:chemically induced* / Q000628:therapy; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000628:therapy; D012658:Sella Turcica; D012867:Skin / Q000187:drug effects; D013997:Time Factors
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate